JL Demory

1.5k total citations
10 papers, 1.2k citations indexed

About

JL Demory is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, JL Demory has authored 10 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Genetics and 2 papers in Molecular Biology. Recurrent topics in JL Demory's work include Acute Myeloid Leukemia Research (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Chronic Myeloid Leukemia Treatments (3 papers). JL Demory is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Chronic Myeloid Leukemia Treatments (3 papers). JL Demory collaborates with scholars based in France, Italy and Denmark. JL Demory's co-authors include F Bauters, Brigitte Dupriez, JL Laï, Pierre Morel, Isabelle Plantier, Michèle Simon, R. Beuscart, J P Jouet, P Fenaux and M Deminatti and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Clinical Microbiology.

In The Last Decade

JL Demory

10 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
JL Demory France 9 1.0k 981 434 362 42 10 1.2k
Thomas Stübig Germany 15 573 0.6× 242 0.2× 268 0.6× 112 0.3× 8 0.2× 25 792
JM Goldman United Kingdom 16 1.0k 1.0× 482 0.5× 140 0.3× 220 0.6× 7 0.2× 20 1.2k
Hikaru Kobayashi Japan 12 300 0.3× 124 0.1× 153 0.4× 51 0.1× 49 1.2× 24 560
Evgeny Klyuchnikov Germany 15 615 0.6× 203 0.2× 183 0.4× 86 0.2× 8 0.2× 57 715
Angela Brisci Italy 9 412 0.4× 441 0.4× 299 0.7× 119 0.3× 13 669
Kyongok Im South Korea 12 152 0.2× 165 0.2× 146 0.3× 63 0.2× 28 0.7× 37 361
Hans-Jochen Kölb Germany 8 548 0.5× 294 0.3× 99 0.2× 106 0.3× 11 666
Rosemary E. Millard United Kingdom 14 207 0.2× 218 0.2× 101 0.2× 34 0.1× 4 0.1× 24 483
Bruce Petersen United States 13 506 0.5× 370 0.4× 580 1.3× 91 0.3× 26 966
Odile Beyne Rauzy France 9 450 0.4× 173 0.2× 180 0.4× 47 0.1× 31 608

Countries citing papers authored by JL Demory

Since Specialization
Citations

This map shows the geographic impact of JL Demory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JL Demory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JL Demory more than expected).

Fields of papers citing papers by JL Demory

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JL Demory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JL Demory. The network helps show where JL Demory may publish in the future.

Co-authorship network of co-authors of JL Demory

This figure shows the co-authorship network connecting the top 25 collaborators of JL Demory. A scholar is included among the top collaborators of JL Demory based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JL Demory. JL Demory is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Desterke, Christophe, Christophe Martinaud, Bernadette Guerton, et al.. (2015). Tetraspanin CD9 participates in dysmegakaryopoiesis and stromal interactions in primary myelofibrosis. Haematologica. 100(6). 757–767. 6 indexed citations
2.
Merlat, A, Yvon Sterkers, JL Demory, et al.. (1999). Therapy-related myelodysplastic syndrome and acute myeloid leukemia with 17p deletion. A report on 25 cases. Leukemia. 13(2). 250–257. 66 indexed citations
3.
Dupriez, Brigitte, Pierre Morel, JL Demory, et al.. (1996). Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system [see comments]. Blood. 88(3). 1013–1018. 404 indexed citations
4.
Bousse‐Kerdilès, Marie‐Caroline Le, Sylvie Chevillard, Agnès Charpentier, et al.. (1996). Differential expression of transforming growth factor-beta, basic fibroblast growth factor, and their receptors in CD34+ hematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasia. Blood. 88(12). 4534–4546. 109 indexed citations
5.
Dupriez, Brigitte, Pierre Morel, JL Demory, et al.. (1996). Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system [see comments]. Blood. 88(3). 1013–1018. 335 indexed citations
7.
Detourmignies, Laurence, Sylvie Castaigné, A. M. Stoppa, et al.. (1992). Therapy-related acute promyelocytic leukemia: a report on 16 cases.. Journal of Clinical Oncology. 10(9). 1430–1435. 79 indexed citations
8.
Decoster, A., Julia Simon, C. Bazin, et al.. (1991). Platelia-Toxo IgA, a new kit for early diagnosis of congenital toxoplasmosis by detection of anti-P30 immunoglobulin A antibodies. Journal of Clinical Microbiology. 29(10). 2291–2295. 30 indexed citations
9.
Demory, JL, Brigitte Dupriez, P Fenaux, et al.. (1988). Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: a report on 47 cases. Blood. 72(3). 855–859. 78 indexed citations
10.
Demory, JL, Brigitte Dupriez, P Fenaux, et al.. (1988). Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: a report on 47 cases. Blood. 72(3). 855–859. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026